Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI
NCT: NCT07037966 · RECRUITING
Brief Summary
Mobile imaging diagnostic devices are extremely valuable for clinical diagnosis both inside and outside healthcare facilities. However, Magnetic Resonance Imaging (MRI)-the gold standard for diagnosing many neurological and musculoskeletal conditions-is not easily portable. Moreover, due to its high cost (in the million-euro range) and limited availability, the average wait time in Europe for an MRI scan is from several weeks to months. The NextMRI project aims to take the technical, industrial, and commercial steps required to deploy portable low-field MRI systems in remote and developing regions, rural areas, sporting events, military or medical camps, and home healthcare settings, improving diagnostic capabilities. The specific goals of the NextMRI project are: 1. Expand current low-field MRI technology to brain imaging. 2. Enhance diagnostic accuracy using machine learning. 3. Improve portability and usability for end users. 4. Reduce production costs for broader affordability. 5. Collect clinical evidence through trials to validate medical performance. 6. Develop a sustainable business model for market commercialization.
Frequently Asked Questions
What is Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI?
Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI is a clinical trial registered under NCT07037966. Current status: RECRUITING.
What is the status of NCT07037966?
The current status of NCT07037966 (Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI) is: RECRUITING.
When did Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI start?
Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI started on 2025-11-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.